Moneycontrol PRO
Loans
HomeNewsErislifesciences

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Trade Spotlight: How should you trade Ashok Leyland, HDFC AMC, Grasim, UltraTech Cement, ONGC, Macrotech Developers and others on May 16?

    Trade Spotlight: How should you trade Ashok Leyland, HDFC AMC, Grasim, UltraTech Cement, ONGC, Macrotech Developers and others on May 16?

    Bulls appear to be in healthy momentum and may continue driving the market rally further. Below are some short-term trading ideas to consider.

  • Trade Spotlight: How should you trade TCS, HDFC Bank, CIE Automotive, Afcons Infrastructure, Eris Lifesciences, and others on Tuesday?

    Trade Spotlight: How should you trade TCS, HDFC Bank, CIE Automotive, Afcons Infrastructure, Eris Lifesciences, and others on Tuesday?

    The momentum is expected to remain positive, but considering the 1,000-point rally over the last two sessions, some consolidation cannot be ruled out. Below are some trading ideas for the near term.

  • Hot Stocks | Radico Khaitan, Ingersoll Rand India, Eris Lifesciences can give up to 16% return in short term

    Hot Stocks | Radico Khaitan, Ingersoll Rand India, Eris Lifesciences can give up to 16% return in short term

    Though Nifty has witnessed a sharp correction, it remains in an intermediate uptrend as long as it is trading above the important support level of 15,500, said Nandish Shah of HDFC securities.

  • Mid, small-caps outperform benchmarks in FY21; these 12 stocks can give up to 56% return in FY22

    Mid, small-caps outperform benchmarks in FY21; these 12 stocks can give up to 56% return in FY22

    By providing attractive valuations, the COVID-19 pandemic seems to have offered an opportunity to investors who have been eyeing the mid and small-cap space to place their bets at significantly low risk, say experts.

  • Hot Stocks: Here’s why JB Chemicals & Eris Lifesciences could give over 12% returns in 3-4 weeks

    Hot Stocks: Here’s why JB Chemicals & Eris Lifesciences could give over 12% returns in 3-4 weeks

    If 11,800 levels get violated decisively on the downside then we might witness further sell-off in prices towards 11,700 levels as well.

  • Nifty likely to show sharp recovery, rally up to 11,410; Motherson Sumi among 3 top buy ideas

    Nifty likely to show sharp recovery, rally up to 11,410; Motherson Sumi among 3 top buy ideas

    A sustained trade above 10,855 will trigger a short covering rally to levels of 11,205-11,410, says Aditya Agarwala of YES Securities

  • As market inches towards record highs, these 25 stocks may return up to 54%

    As market inches towards record highs, these 25 stocks may return up to 54%

    With challenges on the macro front and increasing political headwinds faced by the BJP heading into the 2019 general elections, Prabhudas Lilladher believes traders are likely to remain cautious

  • Nifty likely to face resistance around 10,250; 3 stocks which can give up to 13% return

    Nifty likely to face resistance around 10,250; 3 stocks which can give up to 13% return

    On any bounce in prices, the Nifty index will face strong resistance around 10,250-10,300 levels.

  • Markets@Moneycontrol: Nifty likely to open higher; 3 stocks which can give up to 13% return

    Markets@Moneycontrol: Nifty likely to open higher; 3 stocks which can give up to 13% return

    Trends on SGX Nifty indicate a flat to positive opening for the broader index in India, a rise of 4 points or 0.04 percent.

  • Buy, Sell, Hold: 9 stocks are on investors radar today

    Buy, Sell, Hold: 9 stocks are on investors radar today

    Eris Life, Whirlpool and Gujarat Gas, among others, are being tracked by investors on Tuesday.

  • Buy, Sell, Hold: Analysts are tracking these 6 stocks today

    Buy, Sell, Hold: Analysts are tracking these 6 stocks today

    NTPC, IndiGo and Quess Corp, among others, are on investors’ radar on Tuesday.

  • These 7 stocks that saw double-digit growth in free cash flow over last 4 fiscals

    These 7 stocks that saw double-digit growth in free cash flow over last 4 fiscals

    Moneycontrol ran an analysis of companies which generated consistently double-digit growth in cash flows in the last four fiscal years.

  • Here are SP Tulsian's top trading ideas

    Here are SP Tulsian's top trading ideas

    In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.

  • Is Eris Lifesciences the correct prescription for you?

    Is Eris Lifesciences the correct prescription for you?

    With a predominant focus on the domestic formulations market, a robust portfolio of largely prescription-based drugs, and a tilt towards a promising chronic portfolio, the company seems fundamentally strong.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347